BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36121574)

  • 1. An anti-alcoholism drug, disulfiram and copper complex improves radio-resistance of tumor-initiating cells in esophageal squamous cell carcinoma.
    Qian L; Murakami K; Toyozumi T; Matsumoto Y; Otsuka R; Sekino N; Endo S; Kinoshita K; Sasaki T; Matsubara H
    Esophagus; 2023 Jan; 20(1):134-142. PubMed ID: 36121574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting cancer stem cells by disulfiram and copper sensitizes radioresistant chondrosarcoma to radiation.
    Wang K; Michelakos T; Wang B; Shang Z; DeLeo AB; Duan Z; Hornicek FJ; Schwab JH; Wang X
    Cancer Lett; 2021 May; 505():37-48. PubMed ID: 33582212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disulfiram targets cancer stem-like properties and the HER2/Akt signaling pathway in HER2-positive breast cancer.
    Kim JY; Cho Y; Oh E; Lee N; An H; Sung D; Cho TM; Seo JH
    Cancer Lett; 2016 Aug; 379(1):39-48. PubMed ID: 27238567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disulfiram Acts as a Potent Radio-Chemo Sensitizer in Head and Neck Squamous Cell Carcinoma Cell Lines and Transplanted Xenografts.
    Yao W; Qian X; Ochsenreither S; Soldano F; DeLeo AB; Sudhoff H; Oppel F; Kuppig A; Klinghammer K; Kaufmann AM; Albers AE
    Cells; 2021 Feb; 10(3):. PubMed ID: 33671083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disulfiram/copper-disulfiram Damages Multiple Protein Degradation and Turnover Pathways and Cytotoxicity is Enhanced by Metformin in Oesophageal Squamous Cell Carcinoma Cell Lines.
    Jivan R; Damelin LH; Birkhead M; Rousseau AL; Veale RB; Mavri-Damelin D
    J Cell Biochem; 2015 Oct; 116(10):2334-43. PubMed ID: 25846272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic effect of disulfiram/copper on human cervical cancer cell lines and LGR5-positive cancer stem-like cells.
    Cao HZ; Yang WT; Zheng PS
    BMC Cancer; 2022 May; 22(1):521. PubMed ID: 35534815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncTUG1/miR-144-3p affect the radiosensitivity of esophageal squamous cell carcinoma by competitively regulating c-MET.
    Wang P; Yang Z; Ye T; Shao F; Li J; Sun N; He J
    J Exp Clin Cancer Res; 2020 Jan; 39(1):7. PubMed ID: 31918742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sinomenine hydrochloride on radiosensitivity of esophageal squamous cell carcinoma cells.
    Fu S; Jin L; Gong T; Pan S; Zheng S; Zhang X; Yang T; Sun Y; Wang Y; Guo J; Hui B; Zhang X
    Oncol Rep; 2018 Apr; 39(4):1601-1608. PubMed ID: 29393484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription factor NFE2L3 promotes the proliferation of esophageal squamous cell carcinoma cells and causes radiotherapy resistance by regulating IL-6.
    Chen T; Xu B; Chen H; Sun Y; Song J; Sun X; Zhang X; Hua W
    Comput Methods Programs Biomed; 2022 Nov; 226():107102. PubMed ID: 36108571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldehyde Dehydrogenase-1 Expression Predicts Unfavorable Outcomes in Patients with Esophageal Squamous Cell Carcinoma.
    Ji Y; Li X; Li Y; Zhong Y; Cao J; Xu R; Wang J; Zhou F; Li X; Yu D; Wen JG; Goscinski MA; Zhang M; Nesland JM; Suo Z
    Anticancer Res; 2016 Jan; 36(1):343-9. PubMed ID: 26722063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disulfiram eradicates tumor-initiating hepatocellular carcinoma cells in ROS-p38 MAPK pathway-dependent and -independent manners.
    Chiba T; Suzuki E; Yuki K; Zen Y; Oshima M; Miyagi S; Saraya A; Koide S; Motoyama T; Ogasawara S; Ooka Y; Tawada A; Nakatsura T; Hayashi T; Yamashita T; Kaneko S; Miyazaki M; Iwama A; Yokosuka O
    PLoS One; 2014; 9(1):e84807. PubMed ID: 24454751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Pro-oxidant Therapy Through Copper Redox Cycling:
    Rieber M
    Curr Pharm Des; 2020; 26(35):4461-4466. PubMed ID: 32600223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Cytotoxicity Mechanisms of Copper Complexed with Disulfiram in Oral Cancer Cells.
    Chen SY; Chang YL; Liu ST; Chen GS; Lee SP; Huang SM
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem cell marker ALDH1 expression is associated with lymph node metastasis and poor survival in esophageal squamous cell carcinoma: a study from high incidence area of northern China.
    Wang Y; Zhe H; Gao P; Zhang N; Li G; Qin J
    Dis Esophagus; 2012 Aug; 25(6):560-5. PubMed ID: 22098156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PI3Kα inhibitors sensitize esophageal squamous cell carcinoma to radiation by abrogating survival signals in tumor cells and tumor microenvironment.
    Shi JJ; Xing H; Wang YX; Zhang X; Zhan QM; Geng MY; Ding J; Meng LH
    Cancer Lett; 2019 Sep; 459():145-155. PubMed ID: 31173854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The disulfiram/copper complex induces apoptosis and inhibits tumour growth in human osteosarcoma by activating the ROS/JNK signalling pathway.
    Guo W; Zhang X; Lin L; Wang H; He E; Wang G; Zhao Q
    J Biochem; 2021 Oct; 170(2):275-287. PubMed ID: 33792698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting ALDH1A1 by disulfiram/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells.
    Liu X; Wang L; Cui W; Yuan X; Lin L; Cao Q; Wang N; Li Y; Guo W; Zhang X; Wu C; Yang J
    Oncotarget; 2016 Sep; 7(36):58516-58530. PubMed ID: 27542268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disulfiram treatment facilitates phosphoinositide 3-kinase inhibition in human breast cancer cells in vitro and in vivo.
    Zhang H; Chen D; Ringler J; Chen W; Cui QC; Ethier SP; Dou QP; Wu G
    Cancer Res; 2010 May; 70(10):3996-4004. PubMed ID: 20424113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disulfiram/copper shows potent cytotoxic effects on myelodysplastic syndromes via inducing Bip-mediated apoptosis and suppressing autophagy.
    Zha J; Bi S; Deng M; Chen K; Shi P; Feng L; He J; Pu X; Guo C; Zhao H; Li Z; Jiang Y; Song H; Xu B
    Eur J Pharmacol; 2021 Jul; 902():174107. PubMed ID: 33865831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOX2 promotes tumor growth of esophageal squamous cell carcinoma through the AKT/mammalian target of rapamycin complex 1 signaling pathway.
    Gen Y; Yasui K; Nishikawa T; Yoshikawa T
    Cancer Sci; 2013 Jul; 104(7):810-6. PubMed ID: 23510069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.